JIN-A02, a Mutant-Selective Fourth-Generation EGFR Inhibitor, Overcomes C797S-Mediated Resistance and Demonstrates Intracranial Activity in NSCLC
JIN-A02 是一种突变选择性第四代 EGFR 抑制剂，可克服 C797S 介导的耐药性，并在非小细胞肺癌中显示出颅内活性。
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-25-3720
Lee, Eun Ji; Ko, Ji Ae; Kim, Min-Je; Cho, Jae Seok; Han, Ji-Youn; Kim, Sang We; Lee, Ki Hyeong; Shim, Byoung Yong; Sun, Jong-Mu; Nagasaka, Misako; Park, Sewon; Oh, Seung Yeon; Hong, Min Hee; Lee, Jii Bum; Jo, Anna; Seah, Ethan; Cho, Byoung Chul; Lim, Sun Min
